These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21982924)

  • 1. Initial treatment of acute coronary syndromes. Is there a future for MONA acronym after the 2010 guidelines?
    Nikolaou NI; Vrints CJ
    Resuscitation; 2012 Jan; 83(1):e7. PubMed ID: 21982924
    [No Abstract]   [Full Text] [Related]  

  • 2. Time-honored treatments for the initial management of acute coronary syndromes: Challenging the status quo.
    McCarthy CP; Donnellan E; Wasfy JH; Bhatt DL; McEvoy JW
    Trends Cardiovasc Med; 2017 Oct; 27(7):483-491. PubMed ID: 28600103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute coronary syndrome.
    Overbaugh KJ
    Am J Nurs; 2009 May; 109(5):42-52; quiz 53. PubMed ID: 19411905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 5. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute coronary syndrome. Basic pharmacologic notions].
    Sabourin G
    Perspect Infirm; 2010; 7(6):45. PubMed ID: 21141636
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute coronary syndromes].
    Elbaz M; Roncalli J
    Rev Prat; 2008 Sep; 58(14):1527-37. PubMed ID: 18839681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention: NICE technology appraisal guidance.
    Hill RA; Chung H; George E; Longson C; Stevens A
    Heart; 2010 Sep; 96(17):1407-8. PubMed ID: 20801857
    [No Abstract]   [Full Text] [Related]  

  • 9. Updated ESC Guidelines for managing patients with suspected non-ST-elevation acute coronary syndromes.
    Eur Heart J; 2011 Dec; 32(23):2909-10. PubMed ID: 22135069
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute coronary syndromes: a Canadian perspective.
    Fitchett DH
    Can J Cardiol; 2011; 27 Suppl A():S385-6. PubMed ID: 22118041
    [No Abstract]   [Full Text] [Related]  

  • 11. SNAAP to Replace MONA.
    Kinsara AJ
    Am J Cardiol; 2017 Aug; 120(3):e39. PubMed ID: 27742421
    [No Abstract]   [Full Text] [Related]  

  • 12. [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes].
    Bassand JP; Hamm CW; Ardissino D; Boersma E; Budaj A; Fernandez-Aviles F; Fox KA; Hasdai D; Ohman EM; Wallentin L; Wijns W;
    Rev Port Cardiol; 2008 Sep; 27(9):1063-143. PubMed ID: 19044176
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
    Simmons BB; Salzman BE
    J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit?
    Collet JP; Montalescot G
    Int J Cardiol; 2009 Mar; 133(1):8-17. PubMed ID: 19187982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Options and outcomes with different antiplatelet strategies during primary percutaneous coronary intervention.
    Rajan L; Moliterno DJ
    Eur Heart J; 2009 Jul; 30(14):1687-9. PubMed ID: 19429914
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous high-dose aspirin in acute coronary syndromes?
    Pechlaner C
    Crit Care Med; 2010 Nov; 38(11):2267; athor reply 2267-8. PubMed ID: 20959761
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet therapy in acute coronary syndromes.
    Aragam KG; Bhatt DL
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):24-42. PubMed ID: 20924098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel?
    Wiviott SD
    Cardiol Clin; 2008 Nov; 26(4):629-37. PubMed ID: 18929236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient.
    Cross J
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S48-53. PubMed ID: 19355809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes.
    Chew DP; Anderson FA; Avezum A; Eagle KA; FitzGerald G; Gore JM; Dedrick R; Brieger D;
    Heart; 2010 Aug; 96(15):1201-6. PubMed ID: 20530127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.